Physician profile
Adit Gadh
NPI 1033785944
$2,386.72
in general payments reported to CMS, 2019-2025
7 companies · $1,530 in 2025
The $1,530 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.37 · 2023: $144 · 2024: $687 · 2025: $1,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,160 · Travel and Lodging: $871 · Education: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.76 |
| Travel and Lodging | $870.60 |
| Education | $330.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,492.93 | 2023-2025 | Patient-Fitted Tmj Reconstructive Prosthesis System, Vsp System, Vsp Cranial, Na |
| Medical Device Business Services, INC. | $364.76 | 2024-2025 | Matrixcombo |
| Acera Surgical, INC. | $225.85 | 2025 | Restrata Wound Matrix |
| Kerecis Limited | $201.80 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Zimvie INC. | $39.84 | 2023 | |
| Straumann USA LLC | $36.17 | 2024 | |
| Nobel Biocare USA | $25.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adit Gadh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.